The Irish Times Interviews Prof. Luke O'Neill About New Advances in Blocking Inflammation

The Irish Times interviewed Prof Luke O'Neill about his research in using small molecules to block inflammation. Early mice studies show exceptional promise in blocking multiple sclerosis, and additional tests reveal the molecules could also halt diseases such as rheumatoid arthritis and alzheimer’s. Read the full article here.

Read the full article


If you are a member of the media and have a media query please contact:

Contact Us

Speak to us about
a better tomorrow

Contact Us